OrthoDx is an Australian company established by doctors for doctors, with a commitment to changing the future of orthopaedic diagnostics through genomics.
Using proprietary biomarkers and existing PCR technology, OrthoDx has developed Synvichor™, a world-first genomic PCR test that is able to differentiate between infectious and non-infectious joint pain in a matter of hours.
OrthoDx have harnessed the power of the human immune system to translate key clinical information about the body’s response to infection, rapidly and reliably.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Sydney, Nsw 2000, Au
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- orthodx.com.au
- Keywords
- Biotechnology, Genomics, Orthopaedics, Sepsis, Joint Infection, Diagnostics, Inflammation, PCR, Innovation, Medicine, Surgery, Health Economics, Prosthetic joints, Native joints, Patient outcomes, Quality of life, Clinical outcomes, HighPlex, Host response.
- HQ
- Sydney, NSW
Orthodx Questions
Orthodx's website is orthodx.com.au
Orthodx's LinkedIn profile is https://au.linkedin.com/company/orthodx
Orthodx has
3 employees.
View email and phone details for 3
employees at Orthodx.
Orthodx's industry is
Biotechnology Research
Orthodx's categories are Biotechnology Research
Orthodx's founding year is 2019
